<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The antiphospholipid or <z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e> is the association between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL), venous and arterial thromboses and pregnancy morbidity </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) commonly coexists with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> usually <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), when it is known as secondary APS </plain></SENT>
<SENT sid="2" pm="."><plain>When present in isolation it is known as primary APS (PAPS) </plain></SENT>
<SENT sid="3" pm="."><plain>Although the kidney may be affected in APS, its involvement is perhaps not as well described as that of other organs </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">Thrombotic microangiopathy</z:e> (<z:chebi fb="39" ids="18139,53050">TMA</z:chebi>) affecting the kidney has been reported as a manifestation in both primary and secondary APS </plain></SENT>
<SENT sid="5" pm="."><plain>This report describes <z:hpo ids='HP_0000822'>hypertension</z:hpo> related to underlying renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> as a presenting symptom of APS </plain></SENT>
</text></document>